Inhaled PGE1: Clinical Trials

1 trial of Inhaled PGE1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Inhaled PGE1: new trials by email Literature Review of Inhaled PGE1 trials Research Report on Inhaled PGE1

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Aerosolized Normal Saline, Inhaled PGE1 - Prematurity, Respiratory Insufficiency
Phase 2TerminatedNICHD Neonatal Research Network72011-11-012019-04-24

Conditions studied

Hypertension, Pulmonary (1)  ·  Premature Birth (1)  ·  Respiratory Distress Syndrome, Newborn (1)  ·  Respiratory Insufficiency (1)

Sponsors

NICHD Neonatal Research Network (1)

Countries

United States (1)

Top investigators

Abhik Das, PhD (1)  ·  Beena Sood, MD (1)  ·  C. Michael Cotten, MD (1)  ·  Jonathan M Klein, MD (1)  ·  Krisa P Van Meurs, MD (1)  ·  Leif Nelin, MD (1)  ·  Martin Keszler, MD (1)  ·  Namasivayam Ambalavanan, MD (1)  ·  Pablo J Sanchez, MD (1)  ·  Robin Ohls, MD (1)  ·  Satyan Lakshminrusimha, MD (1)  ·  Uday Devaskar, MD (1)

Results publications

PMID 25496504

NIH funding

U10HD021385 (1), U10HD027880 (1), U10HD027904 (1), U10HD034216 (1), U10HD036790 (1), U10HD040461 (1), U10HD040492 (1), U10HD040689 (1), U10HD053109 (1), U10HD068263 (1), U10HD068270 (1), U10HD068278 (1)